Advanced search
Publication Cover
Cancer Investigation Volume 24, 2006 - Issue 4
Submit an article Journal homepage
138
Views
36
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Dramatic Regression of Multiple Brain Metastases from Breast Cancer with Capecitabine: Another Arrow at the Bow?

A. Fabi Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
, M.D.,
A. Vidiri Department of Diagnostic of Imaging, Regina Elena National Cancer Institute, Rome, Italy
,
G. Ferretti Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
,
A. Felici Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
,
P. Papaldo Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
,
P. Carlini Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
,
A. Mirri Service of Radiotherapy, Regina Elena National Cancer Institute, Rome, Italy
,
C. Nuzzo Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
&
F. Cognetti Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
 show all
Pages 466-468 | Published online: 11 Jun 2009

REFERENCES

  • Batchelor T. T., Gatineau M. P., Supko J. G. Pharmacologic considerations in chemotherapy for brain tumors. Cancer Chemotherapy and Biotherapy: Principles and Practice, B. A. Chabner, D. L. Longo. Lippincott Williams & Wilkins, Philadelphia 2001
  • Cordon-Cardo C., O'Brien J. P., Casals D. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 1989; 86: 695–698, [INFOTRIEVE], [CSA]
  • Lin N. U., Bellon J. R., Winer E. P. CNS metastases in breast cancer. J. Clin. Oncol. 2004; 22(17)3608–3617, [INFOTRIEVE], [CROSSREF], [CSA]
  • Rosner D., Nemoto T., Lane W. W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986; 58: 832–839, [INFOTRIEVE], [CSA]
  • Boogerd W., Dalesio O., Bais E. M., van der Sande J. J. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992; 69(4)972–980, [INFOTRIEVE], [CSA]
  • Tsukamoto Y., Kato Y., Ura M., Horii I., Ishitsuka H., Kusuhara H., Sugiyama Y. A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. Pharm. Res. 2001; 18: 1190–1202, [INFOTRIEVE], [CROSSREF], [CSA]
  • Ishikawa T., Fukase Y., Yamamoto T., Sekiguchi F., Ishitsuka H. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5′-deoxy-5-fluorocytidine (capecitabine). Biol. Pharm. Bull. 1998; 21: 713–717, [INFOTRIEVE], [CSA]
  • Ishikawa T., Sekiguchi F., Fukase Y., Sawada N., Ishitsuka H. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res. 1998; 58: 685–690, [INFOTRIEVE], [CSA]
  • Wang M. L.H., Yung W. K., Royce M. E., Schomer D. F., Theriault R. L. Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. Am. J. Clin. Oncol. 2001; 24(4)421–424, [INFOTRIEVE], [CROSSREF], [CSA]
  • Blanquicett C., Gillespie G. Y., Nabors L. B., Miller C. R., Bharara S., Buchsbaum D. J., Diasio R. B., Johnson M. R. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation. Mol. Cancer Ther. 2002; 1(12)1139–1145, [INFOTRIEVE], [CSA]
  • Sawada N., Ishikawa T., Sekiguchi F., Tanaka Y., Ishitsuka H. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin. Cancer Res. 1995; 2948–2953, [CSA]
  • Wilke H. Future treatment options with capecitabine in solid tumours. Eur. J. Cancer 2002; 38: 21–25, [INFOTRIEVE], [CROSSREF], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.